TTM
$7.08
YoY change
+4173.3%
5Y CAGR
—
Peak year (2025)
$6.41
Latest annual
$6.41
EPS (Diluted) history chart for Incyte (INCY) from 1993 to 2025
Latest: $6.41
EPS (Diluted) growth chart for Incyte (INCY) from 1993 to 2025
Latest: +4173.3%
EPS (Diluted) history table for Incyte (INCY) from 1993 to 2025
| 2025 | $6.41 | +4173.3% | +$6.26 | ||
| 2024 | $0.15 | -94.3% | −$2.50 | ||
| 2023 | $2.65 | +74.3% | +$1.13 | ||
| 2022 | $1.52 | -64.4% | −$2.75 | ||
| 2021 | $4.27 | -414.0% | +$5.63 | ||
| 2020 | −$1.36 | -166.3% | −$3.41 | ||
| 2019 | $2.05 | +302.0% | +$1.54 | ||
| 2018 | $0.51 | -133.3% | +$2.04 | ||
| 2017 | −$1.53 | -383.3% | −$2.07 | ||
| 2016 | $0.54 | +1700.0% | +$0.51 | ||
| 2015 | $0.03 | -110.3% | +$0.32 | ||
| 2014 | −$0.29 | -48.2% | +$0.27 | ||
| 2013 | −$0.56 | +64.7% | −$0.22 | ||
| 2012 | −$0.34 | -77.2% | +$1.15 | ||
| 2011 | −$1.49 | +473.1% | −$1.23 | ||
| 2010 | −$0.26 | -87.4% | +$1.80 | ||
| 2009 | −$2.06 | +3.5% | −$0.07 | ||
| 2008 | −$1.99 | +93.2% | −$0.96 | ||
| 2007 | −$1.03 | +15.7% | −$0.14 | ||
| 2006 | −$0.89 | -28.2% | +$0.35 | ||
| 2005 | −$1.24 | -43.9% | +$0.97 | ||
| 2004 | −$2.21 | -5.2% | +$0.12 | ||
| 2003 | −$2.33 | +14.8% | −$0.30 | ||
| 2002 | −$2.03 | -26.7% | +$0.74 | ||
| 2001 | −$2.77 | +489.4% | −$2.30 | ||
| 2000 | −$0.47 | -2.1% | +$0.01 | ||
| 1999 | −$0.48 | -900.0% | −$0.54 | ||
| 1998 | $0.06 | -53.8% | −$0.07 | ||
| 1997 | $0.13 | -176.5% | +$0.30 | ||
| 1996 | −$0.17 | -45.2% | +$0.14 | ||
| 1995 | −$0.31 | -24.4% | +$0.10 | ||
| 1994 | −$0.41 | +115.8% | −$0.22 | ||
| 1993 | −$0.19 | — | — |
- 2025$6.41+4173.3%
- 2024$0.15-94.3%
- 2023$2.65+74.3%
- 2022$1.52-64.4%
- 2021$4.27-414.0%
- 2020−$1.36-166.3%
- 2019$2.05+302.0%
- 2018$0.51-133.3%
- 2017−$1.53-383.3%
- 2016$0.54+1700.0%
- 2015$0.03-110.3%
- 2014−$0.29-48.2%
- 2013−$0.56+64.7%
- 2012−$0.34-77.2%
- 2011−$1.49+473.1%
- 2010−$0.26-87.4%
- 2009−$2.06+3.5%
- 2008−$1.99+93.2%
- 2007−$1.03+15.7%
- 2006−$0.89-28.2%
- 2005−$1.24-43.9%
- 2004−$2.21-5.2%
- 2003−$2.33+14.8%
- 2002−$2.03-26.7%
- 2001−$2.77+489.4%
- 2000−$0.47-2.1%
- 1999−$0.48-900.0%
- 1998$0.06-53.8%
- 1997$0.13-176.5%
- 1996−$0.17-45.2%
- 1995−$0.31-24.4%
- 1994−$0.41+115.8%
- 1993−$0.19—
EPS (Diluted) values are taken from Incyte's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Incyte (INCY)
According to Incyte's latest reported financial statements, the company's current diluted EPS (TTM) is $7.08. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Incyte (INCY) reported diluted EPS of $6.41 – surged 4173.3% year-over-year.
Across 2015–2025 (10 years), Incyte diluted EPS produced a CAGR of +71.0% – with mixed annual results across the window.
Across the available history, diluted EPS reached its high of $6.41 in 2025 and its low of −$2.77 in 2001.
Incyte EPS (Diluted) by Year
Incyte EPS (Diluted) 2025: $6.41
In 2025, Incyte reported diluted EPS of $6.41, surged 4173.3% from 2024. This figure represents the highest annual value in the available history.
Incyte EPS (Diluted) 2024: $0.15
Incyte diluted EPS in 2024 was $0.15, plunged 94.3% below 2023.
Incyte EPS (Diluted) 2023: $2.65
2023's diluted EPS for Incyte came in at $2.65, surged 74.3% from 2022.
Incyte EPS (Diluted) 2022: $1.52
Incyte posted diluted EPS of $1.52 in 2022, plunged 64.4% below 2021.
Incyte EPS (Diluted) 2021: $4.27
Incyte diluted EPS in 2021 was $4.27.
See more financial history for Incyte (INCY). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Incyte (INCY), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Incyte (INCY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation